HeraMED (STU:1I4) Operating Margin %: -1,142.53% (As of Dec. 2025)


What is HeraMED Operating Margin %?

HeraMED STU:1I4 +5.00% Operating Margin % is -1,142.53% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, HeraMED ranks worse than 94.61% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. HeraMED's Operating Income for the six months ended in Dec. 2025 was €-0.99 Mil. HeraMED's Revenue for the six months ended in Dec. 2025 was €0.09 Mil. Therefore, HeraMED's Operating Margin % for the quarter that ended in Dec. 2025 was -1,142.53%.

Good Sign:

HeraMED Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for HeraMED's Operating Margin % or its related term are showing as below:

STU:1I4' s Operating Margin % Range Over the Past 10 Years
Min: -8800   Med: -1873.73   Max: -1100.85
Current: -1229.69


STU:1I4's Operating Margin % is ranked worse than
94.61% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs STU:1I4: -1229.69

HeraMED's 5-Year Average Operating Margin % Growth Rate was 31.80% per year.

HeraMED's Operating Income for the six months ended in Dec. 2025 was €-0.99 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.04 Mil.


HeraMED  (STU:1I4) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


HeraMED Operating Margin % Related Terms


HeraMED Operating Margin % Historical Data

* Premium members only.

The historical data trend for HeraMED's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeraMED Operating Margin % Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial -4,526.32 -1,453.17 -1,100.00 -1,530.91 -1,231.33

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,119.89 -1,841.96 -1,212.61 -1,339.74 -1,142.53

STU:1I4 vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, HeraMED's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeraMED Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Operating Margin % distribution charts can be found below:

* The bar in red indicates where HeraMED's Operating Margin % falls into.



HeraMED Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

HeraMED's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-2.044 / 0.166
=-1,231.33 %

HeraMED's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-0.994 / 0.087
=-1,142.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -1,142.53% mean?
HeraMED (STU:1I4) has a Operating Margin % of -1,142.53% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on HeraMED and its competitors. According to the industry distribution chart, HeraMED ranks #772 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 94.6%.
Is HeraMED's Operating Margin % too high?
HeraMED's current Operating Margin % is -1,142.53%. Based on the distribution chart, HeraMED ranks #772 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does HeraMED's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HeraMED ranks #772 out of 816 companies for Operating Margin %. This places HeraMED in the lower half of its industry. The industry median Operating Margin % is 3.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on HeraMED and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeraMED's current Operating Margin % is -1,142.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (STU:1I4) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 110% above its estimated fair value. The current Operating Margin % is -1,142.53%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For HeraMED (STU:1I4), the current Operating Margin % is -1,142.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeraMED Business Description

Other Exchanges 1I4:GermanyHMD:Australia
Address 117 Camberwell Road, Level 1 - Suite 1, Hawthorn East, Melbourne, VIC, AUS, 3123
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.